Creative Medical Technology Inc.
CELZ | NASDAQ
$1
+$0.03 (+3.53%)
At close: Sep 21, 2026, 4:00 PM ET
$0.99
-$0.01 (-1.00%)
After-hours:
Sep 21, 2026, 7:59 PM ET
Market Data
Market Cap $2.49M
Enterprise Value $-6.12M
Beta 2.04
Average Volume 6.77M
Shares Outstanding (Diluted) 3.7M
Shares Change YoY 43.45%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US22529Y4089
Price Performance
Price Change 1M -22.5%
Price Change 3M -49.2%
Price Change 6M -46.5%
Price Change YTD -49.2%
Price Change 1Y -71.3%
Price Change 3Y -80.9%
Price Change 5Y -98.8%
1M CAGR (ann.) -16.0%
1Y CAGR (ann.) -73.4%
5Y CAGR (ann.) -60.2%
All-Time CAGR -56.5%
Valuation
PE Ratio -0.50
Forward PE N/A
PEG Ratio -0.01
Forward PEG 0.02
PS Ratio 864.52
Forward PS 0.10
PB Ratio 0.30
P/FCF Ratio -0.44
P/Adj. FCF Ratio -0.44
P/OCF Ratio -0.63
EV/Sales -2,040.18
EV/EBIT 1.32
EV/EBITDA 1.35
EV/FCF 1.04
Earnings Yield -200.0%
FCF Yield -227.6%
Adj. FCF Yield -227.6%
Financial Health
Net Cash $8.71M
Total Debt $0
Cash & Short-Term Investments $8.71M
Total Assets $9.38M
Current Ratio 12.91
Quick Ratio 12.73
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -9.40
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin -1732.4%
Operating Profit Margin -155932.3%
EBITDA Margin -202975.0%
Net Profit Margin -201355.4%
FCF Margin -196723.9%
Adj. FCF Margin -196723.9%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -64.4%
Return on Equity -86.7%
Return on Invested Capital -71.9%
Return on Capital Employed -71.9%
Return on Tangible Assets -67.0%
Historical Growth (CAGR)
Revenue CAGR 3Y -65.6%
Revenue CAGR 5Y -50.8%
Revenue CAGR 10Y -11.5%
EPS CAGR 3Y 33.6%
EPS CAGR 5Y 51.9%
EPS CAGR 10Y 43.8%
FCF CAGR 3Y -2.0%
FCF CAGR 5Y 1.1%
FCF CAGR 10Y -22.3%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 87.0%
Revenue Growth Next 3Y 2951.5%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-5.9M
Free Cash Flow $-5.9M
Adj. Free Cash Flow $-5.9M
FCF Per Share -$1.59
OCF Per Share -$1.59
OCF/S Ratio -196723.9%
Income Statement
Revenue $3K
Gross Profit $-29.05K
Operating Income $-4.68M
EBITDA $-4.55M
Net Income $-6.04M
EPS (Diluted) -$2
Revenue / Employee $750
Profit / Employee $-1.51M
Employees 4
Add to Watchlist
Select watchlists to add or remove CELZ